Clinical Trials Directory

Trials / Completed

CompletedNCT06414018

Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment

Effect of Equivalent Dose of Alfentanil and Sufentanil Combined With Remimazolam in Complex Bronchoscopic Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The equivalent dose of sufentanil and afentanil combined with laryngeal mask was used for complex bronchoscopy to observe the intraoperative effect and the influence on the recovery of patients

Detailed description

Afentanil is a powerful, fast-acting narcotic analgesic, which can effectively inhibit intubation reflex. Compared with sufentanil, it has a short half-life and is safer, and can be used as the first choice for short surgical analgesics. In this study, by comparing the use of equivalent dose sufentanil and afentanil combined with laryngeal mask for complex bronchoscopy, the intraoperative analgesic effect and the influence on the recovery of patients were observed, and a better anesthesia scheme was provided for tracheoscopy.

Conditions

Interventions

TypeNameDescription
DRUGAlfentanilalfentanil 10ug/kg is used for anesthesia induction

Timeline

Start date
2024-05-20
Primary completion
2024-12-25
Completion
2024-12-28
First posted
2024-05-14
Last updated
2025-01-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06414018. Inclusion in this directory is not an endorsement.